Close Menu

Protea Biosciences

The partners aim to develop a diagnostic methodology for obtaining cancer cell molecular profiles to help guide immunotherapies.

The companies will market Proteos' protein production services alongside Protea's bioanalytical services.

This week's news includes Ambry Genetics, DNAstack, Protea Biosciences Group, Exosome Diagnostics, BGI Europe, and Castle Biosciences.

The mass spectrometry services and instrument firm is working with a Yale pathologist to develop proteomic tests for solid tumors.

The test using proteomic mass spectrometry imaging to separate cancerous spots from benign moles was developed jointly by scientists at Protea and Yale.

Protea will purchase the research services firm with cash and Series A stock, but must first raise at least $10 million in debt or equity.

The partners will use mass spectrometry to study the occupational hazards of inhaling aerosols that are released during welding and electronic manufacturing.

NEW YORK (GenomeWeb) – Protea Biosciences and InSphero today said they will combine their 3D technologies into new products and services to be marketed to the pharmaceutical and biotechnology markets.

NEW YORK (GenomeWeb) – Protea Biosciences Group today said that it has signed an agreement to collaborate with the University of Southampton to identify biomarkers that may indicate a risk of developing Alzheimer's disease.

NEW YORK (GenomeWeb) – Protea Biosciences Group said today that it has undertaken a collaborative research effort with Memorial Sloan Kettering Cancer Center and the Dana-Farber Cancer Institute with an initial focus on lung cancer.

Pages

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.